{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:58:22Z","timestamp":1792511902816,"version":"4.5.0"},"reference-count":42,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2024,5,16]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Severe exacerbation of chronic obstructive pulmonary disease (COPD) is a trajectory-changing life event for patients and a major contributor to health system costs. This study evaluates the real-world impact of a primary care, integrated disease management (IDM) programme on acute health service utilisation (HSU) in the Canadian health system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Interrupted time series analysis using retrospective health administrative data, comparing monthly HSU event rates 3 years prior to and 3 years following the implementation of COPD IDM. Primary outcomes were COPD-related hospitalisation and emergency department (ED) visits. Secondary outcomes included hospital bed days and all-cause HSU.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 2451 participants. COPD-related and all-cause HSU rates increased in the 3 years prior to IDM implementation. With implementation, there was an immediate decrease (month 1) in COPD-related hospitalisation and ED visit rates of \u22124.6 (95% CI: \u22127.76 to \u20131.39) and \u22126.2 (95% CI: \u201311.88, \u20130.48) per 1000 participants per month, respectively, compared with the counterfactual control group. After 12 months, COPD-related hospitalisation rates decreased: \u22129.1 events per 1000 participants per month (95% CI: \u201312.72, \u20135.44) and ED visits \u221219.0 (95% CI: \u201325.50, \u201312.46). This difference nearly doubled by 36 months. All-cause HSU also demonstrated rate reductions at 12 months, hospitalisation was \u221210.2 events per 1000 participants per month (95% CI: \u201315.79, \u20134.44) and ED visits were \u221230.4 (95% CI: \u201341.95, \u201318.78).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Implementation of COPD IDM in a primary care setting was associated with a changed trajectory of COPD-related and all-cause HSU from an increasing year-on-year trend to sustained long-term reductions. This highlights a substantial real-world opportunity that may improve health system performance and patient outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2023-221211","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:21:39Z","timestamp":1718731299000},"page":"725-734","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Quantifying sustained health system benefits of primary care-based integrated disease management for COPD: a 6-year interrupted time series study"],"prefix":"10.1136","volume":"79","author":[{"given":"Christopher","family":"Licskai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-638X","authenticated-orcid":false,"given":"Anna","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madonna","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimball","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Terebessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Scarffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Sibbald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Faulds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"O'Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"2025042101250778000_79.8.725.1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease. 2023. Available: https:\/\/goldcopd.org\/2023-gold-report-2\/ [Accessed 20 Sep 2023]."},{"key":"2025042101250778000_79.8.725.2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1676"},{"key":"2025042101250778000_79.8.725.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069679","article-title":"Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"378","author":"Safiri","year":"2022","journal-title":"BMJ"},{"key":"2025042101250778000_79.8.725.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1179-7","article-title":"Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study","volume":"20","author":"Kirsch","year":"2019","journal-title":"Respir Res"},{"key":"2025042101250778000_79.8.725.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-019-01119-1"},{"key":"2025042101250778000_79.8.725.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-201518"},{"key":"2025042101250778000_79.8.725.7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pulmoe.2022.11.001","article-title":"Severe exacerbations and mortality in COPD patients: a retrospective analysis of the database of the Hungarian national health insurance fund","volume":"29","author":"S\u00e1nta","year":"2023","journal-title":"Pulmonology"},{"key":"2025042101250778000_79.8.725.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201710-2029OC"},{"key":"2025042101250778000_79.8.725.9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-2434"},{"key":"2025042101250778000_79.8.725.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201201-0034OC"},{"key":"2025042101250778000_79.8.725.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201211-2044OC"},{"key":"2025042101250778000_79.8.725.12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1513\/AnnalsATS.201609-717OC","article-title":"Forecasting hospitalization and emergency department visit rates for chronic obstructive pulmonary disease. A time-series analysis","volume":"14","author":"Gershon","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2025042101250778000_79.8.725.13","article-title":"Integrated disease management interventions for patients with chronic obstructive pulmonary disease","volume":"9","author":"Poot","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025042101250778000_79.8.725.14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/resp.13025","article-title":"Australian and New Zealand pulmonary rehabilitation guidelines","volume":"22","author":"Alison","year":"2017","journal-title":"Respirology"},{"key":"2025042101250778000_79.8.725.15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/resp.13518","article-title":"Maintaining the benefits following pulmonary rehabilitation: achievable or not?","volume":"24","author":"Spencer","year":"2019","journal-title":"Respirology"},{"key":"2025042101250778000_79.8.725.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1655","article-title":"Developing and evaluating complex interventions: the new Medical Research Council guidance","volume":"337","author":"Craig","year":"2008","journal-title":"BMJ"},{"key":"2025042101250778000_79.8.725.17","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-019-0119-9","article-title":"The impact of integrated disease management in high-risk COPD patients in primary care","volume":"29","author":"Ferrone","year":"2019","journal-title":"NPJ Prim Care Respir Med"},{"key":"2025042101250778000_79.8.725.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12962-022-00377-w","article-title":"Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting","volume":"20","author":"Scarffe","year":"2022","journal-title":"Cost Eff Resour Alloc"},{"key":"2025042101250778000_79.8.725.19","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2147\/COPD.S416988","article-title":"Estimating the health and economic impact of improved management in prevalent chronic obstructive pulmonary disease populations in England, Germany, Canada, and Japan: a modelling study","volume":"18","author":"Adams","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025042101250778000_79.8.725.20","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.2147\/COPD.S338851","article-title":"Integrated disease management for chronic obstructive pulmonary disease in primary care, from the controlled trial to clinical program: a cohort study","volume":"16","author":"Hussey","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025042101250778000_79.8.725.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-022-07785-x","article-title":"A framework to support the progressive implementation of integrated team-based care for the management of COPD: a collective case study","volume":"22","author":"Sibbald","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2025042101250778000_79.8.725.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-06636-5","article-title":"Evaluating the implementation of a chronic obstructive pulmonary disease management program using the consolidated framework for implementation research: a case study","volume":"21","author":"Paciocco","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"2025042101250778000_79.8.725.23","doi-asserted-by":"crossref","unstructured":"Sibbald SL , Paciocco S , Huizhu Chen L , et al . A peer-to-peer approach to implementation of a chronic disease management program. JRIPE 2023;12. doi:10.22230\/jripe.2022v12n2a343","DOI":"10.22230\/jripe.2022v12n2a343"},{"key":"2025042101250778000_79.8.725.24","unstructured":"Ontario Health . Quality standards: chronic obstructive pulmonary disease, care in the community for adults (2023 update). n.d. Available: https:\/\/www.hqontario.ca\/Portals\/0\/documents\/evidence\/quality-standards\/qs-chronic-obstructive-pulmonary-disease-quality-standard-2023-en.pdf"},{"key":"2025042101250778000_79.8.725.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f403","article-title":"Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses","volume":"346","author":"Hawton","year":"2013","journal-title":"BMJ"},{"key":"2025042101250778000_79.8.725.26","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg459"},{"key":"2025042101250778000_79.8.725.27","doi-asserted-by":"crossref","unstructured":"Sibbald SL , Law B , Van Asseldonk R , et al . Using visual methods to capture patient perspectives in interprofessional team-based care for chronic disease management. JRIPE 2022;12. doi:10.22230\/jripe.2022v12n2a331","DOI":"10.22230\/jripe.2022v12n2a331"},{"key":"2025042101250778000_79.8.725.28","doi-asserted-by":"crossref","first-page":"107836","DOI":"10.1016\/j.pec.2023.107836","article-title":"Patient engagement in Interprofessional team-based chronic disease management: a qualitative description of a Canadian program","volume":"114","author":"Law","year":"2023","journal-title":"Patient Educ Couns"},{"key":"2025042101250778000_79.8.725.29","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211732"},{"key":"2025042101250778000_79.8.725.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909883"},{"key":"2025042101250778000_79.8.725.31","first-page":"21","article-title":"Exacerbations of COPD","volume":"11 Spec Iss","author":"Pavord","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025042101250778000_79.8.725.32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/COPD.S346591","article-title":"Frequency and severity of exacerbations of COPD associated with future risk of exacerbations and mortality: a UK routine health care data study","volume":"17","author":"Whittaker","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025042101250778000_79.8.725.33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-022-02123-5","article-title":"Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review","volume":"23","author":"Hurst","year":"2022","journal-title":"Respir Res"},{"key":"2025042101250778000_79.8.725.34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.chest.2018.12.018","article-title":"Which physicians are taking care of people with COPD?","volume":"155","author":"Cho","year":"2019","journal-title":"Chest"},{"key":"2025042101250778000_79.8.725.35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1164\/rccm.202110-2441OC","article-title":"Prognosis of patients with chronic obstructive pulmonary disease not eligible for major clinical trials","volume":"206","author":"\u00c7olak","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2025042101250778000_79.8.725.36","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00061414"},{"key":"2025042101250778000_79.8.725.37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2025042101250778000_79.8.725.38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/COPD.S231296","article-title":"Impact of comorbidities and commonly used drugs on mortality in COPD \u2013 real-world data from a primary care setting","volume":"15","author":"Ellingsen","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025042101250778000_79.8.725.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713901"},{"key":"2025042101250778000_79.8.725.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916046"},{"key":"2025042101250778000_79.8.725.41","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw098"},{"key":"2025042101250778000_79.8.725.42","doi-asserted-by":"publisher","DOI":"10.1177\/003591576505800503"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-221211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T08:25:48Z","timestamp":1745223948000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-221211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,7,16]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/thorax-2023-221211"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-221211","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}